Development of Novel Oncolytic Vector Based on Alternative Adenovirus Serotype 6 for Glioblastoma and Breast Cancer Therapy

被引：0
|
作者：
Romanenko, Margarita [1 ,2 ]
Osipov, Ivan [2 ]
Kutseikin, Sergei [2 ]
Sizova, Mariia [2 ]
Paramonik, Anastasiya [2 ]
Grazhdantseva, Antonina [3 ]
Kochneva, Galina [3 ]
Davydova, Julia [1 ]
Netesov, Sergey [2 ]
机构：
[1] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA
[2] Novosibirsk State Univ, Novosibirsk, Russia
[3] State Res Ctr Virol & Biotechnol Vector, Koltsov, Russia
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
10
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5
    Sallard, Erwan
    Schulte, Lukas
    van den Boom, Alexander
    Klimovitskii, Alexander
    Knierer, Julius
    Hagedorn, Claudia
    Knocks, Maximilian
    Zhang, Wenli
    Kreppel, Florian
    Ehrhardt, Anja
    Ehrke-Schulz, Eric
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
  • [2] Development of oncolytic and gene therapy vectors based on Adenovirus serotype 4 as an alternative to Adenovirus serotype 5
    Sallard, E.
    Schellhorn, S.
    Knocks, M.
    Schulte, L.
    Klimovitskii, A.
    Zhang, W.
    Ehrke-Schulz, E.
    Ehrhardt, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A127 - A128
  • [3] Development of oncolytic and gene therapy vectors based on Adenovirus serotype 4 as an alternative to Adenovirus serotype 5
    Sallard, E.
    Schellhorn, S.
    Knocks, M.
    Schulte, L.
    Klimovitskii, A.
    van den Boom, A.
    Zhang, W.
    Ehrhardt, A.
    Ehrke-Schulz, E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A52 - A52
  • [4] Development of Adenovirus Serotype 4 Oncolytic and Gene Therapy Vectors as an Alternative to Adenovirus Serotype 5
    Sallard, Erwan
    Schellhorn, Sebastian
    Knocks, Maximilian Maximilian
    Schulte, Lukas
    Klimovitskii, Alexander
    van den Boom, Alexander
    Zhang, Wenli
    Ehrhardt, Anja
    Ehrke-Schulz, Eric
    MOLECULAR THERAPY, 2023, 31 (04) : 565 - 565
  • [5] A Novel Oncolytic Adenovirus Based on Human Adenovirus Serotype 17
    Doerner, Johannes
    Zhang, Wenli
    Liu, Jing
    Solanki, Manish
    Boehme, Philip
    Ehrhardt, Anja
    MOLECULAR THERAPY, 2015, 23 : S47 - S47
  • [6] A novel oncolytic adenovirus based on simian adenovirus serotype 24
    Cheng, Tao
    Song, Yufeng
    Zhang, Yan
    Zhang, Chao
    Yin, Jieyun
    Chi, Yudan
    Zhou, Dongming
    ONCOTARGET, 2017, 8 (16) : 26871 - 26885
  • [7] Development of Novel Vectors Based on Human Adenovirus Serotype 4 as an Alternative to Adenovirus Serotype 5
    Ehrke-Schulz, Eric
    Sallard, Erwan Sallard
    Schellhorn, Sebastian
    Knocks, Maximilian
    Schulte, Lukas
    Klimovitskii, Alexander
    van den Boom, Alexander
    Zhang, Wenli
    Ehrhardt, Anja
    MOLECULAR THERAPY, 2022, 30 (04) : 294 - 294
  • [8] Development of Adenovirus serotype 10 as a vector for gene therapy
    Davies, James
    Uusi-Kerttula, Hanni
    Chester, John
    Parker, Alan
    HUMAN GENE THERAPY, 2017, 28 (08) : A29 - A29
  • [9] Novel oncolytic adenovirus fully composed of adenovirus serotype 35 for treatment of pancreatic cancer
    Ono, Ryosuke
    Sakurai, Fuminori
    Mizuguchi, Hiroyuki
    CANCER SCIENCE, 2022, 113 : 1359 - 1359
  • [10] Enhanced Oncolytic Activity Mediated by a Novel Human Adenovirus Type 6 Based Vector
    Doerner, Johannes
    Zhang, Wenli
    Boehme, Philip
    Ehrhardt, Anja
    MOLECULAR THERAPY, 2016, 24 : S45 - S45
12345